By Scott Flaherty ( June 14, 2013, 8:27 PM EDT) -- A California appeals court Thursday allowed a woman's suit to move forward alleging that Teva Pharmaceuticals USA Inc. and others failed to warn of potential safety issues with a generic osteoporosis drug, finding her claims were not preempted by the U.S. Supreme Court's Mensing decision....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.